Posterior Capsule Opacification (PCO) Evaluation of the AcrySof SN60AT Lens vs. SN60WF Lens

Completed · Not applicable

Conditions studied: Cataract

In brief

To assess posterior capsule opacification (PCO) in patients implanted with either the AcrySof SN60AT lens or the AcrySof SN60WF lens.

Key facts

Study ID

NCT00762021

Run by

Alcon Research

People needed

104

Starts

2006-12-01

Last updated by the study team

2010-12-22

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patients with bilateral senile cataracts
• Age > 50 years
• Fit for hospital follow ups
• Pupils dilating > 6mm preoperatively
• Eyes expected to see 6/12 or better postoperatively

You may not qualify if…

• Diabetes
• On treatment for glaucoma
• Other ocular pathology
• Previous ocular surgery

Where it is running

• Contact Alcon Call Center for Trial Locations — Fort Worth, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.